Rare Cancers – more common than you think
More than 4.3 million people in the European Union are affected by rare cancers. Despite the rarity of each of the 198 rare cancers, they represent in total about 22% of all cancer cases, including all cancers in children, diagnosed in the EU28 each year.
Rare Cancers Europe (RCE) is a multi-stakeholder initiative dedicated to putting rare cancers firmly on the European policy agenda and to implementing 39 political and stakeholder recommendations.
24 Mar 2015
Press Release: Urgent Need For European Reference Networks For Rare Cancers
We need to get this right, because this can be a basis for truly adding value to the most vulnerable of our citizens, and having one European Reference...
23 Mar 2015
Discussion On The Quality Of Care For Rare Cancers In Belgium
An ECPC, RARECAREnet and Belgian Cancer Registry event: Quality of care for rare cancers in Belgium, 16 April 2015
18 Mar 2015
Phase III trial shows positive results for bortezomib-based first-line treatment in mantle-cell lymphoma
Bortezomib based therapy effective in patients with newly diagnosed mantle-cell lymphoma, an incurable, aggressive haematological malignancy